Temixys

Digital Pharmacist

The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.

Temixys is used to treat HIV-1 virus infection. Do not take Temixys with Hepsera (adefovir dipivoxil).

Temixys Overview

Reviewed: December 3, 2018
Updated: 

Temixys is a prescription medication used to treat human immunodeficiency virus-1 (HIV-1) infection in adults and children weighing 35 kg and up.

It is a single product containing 2 medications: lamivudine and tenofovir disoproxil fumarate. Temixys belongs to a group of drugs called nucleoside reverse transcriptase inhibitors which block reverse transcriptase (an HIV-1 enzyme) thereby preventing HIV-1 from replicating.

This medication comes in tablet form and is taken once daily, with or without food.

Common side effects include rash, headache, pain, depression and diarrhea. Temixys can also cause dizziness. Do not drive or operate heavy machinery until you know how Temixys affects you.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Temixys Drug Class

Back to Top

Temixys FDA Warning

Back to Top

WARNING: POSTTREATMENT EXACERBATIONS OF HEPATITIS B

Severe acute exacerbations of hepatitis B have been reported in patients who are co-infected with hepatitis B virus (HBV) and human immunodeficiency virus (HIV-1) and have discontinued lamivudine or tenofovir disoproxil fumarate. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue Temixys and are co-infected with HIV-1 and HBV. If appropriate, initiation of anti- hepatitis B therapy may be warranted.